NeuroPace to repurchase 17.5% stake from KCK at equity offering price

NeuroPace Inc

Agreed to repurchase all shares held by KCK, representing ~17.5% of outstanding common stock.
Repurchase price equals the price per share in the concurrent underwritten equity offering.
Closing conditioned on completion of equity offering; expected no earlier than 2 business days after.
Transaction approved by audit and pricing committees of independent directors.
Repurchased shares will become authorized but unissued.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.